Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Kane Biotech Inc. V.KNE

Alternate Symbol(s):  KNBIF

Kane Biotech Inc. is a Canada-based biotechnology company. The Company is engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. It has a portfolio of biotechnologies and products, which includes StrixNB, DispersinB, Aledex, bluestem, bluestem, silkstem, goldstem, coactiv+, coactiv+, DermaKB and DermaKB Biofilm. Its Wound Care & Surgical division is focused on the product development of DispersinB for applications in chronic wound care. Its bluestem product line includes water additives, chews, spray and dental wipes. Its other products in development stage include Coactiv+, antimicrobial wound rinse for use in acute and chronic wounds; Coactiv+, antimicrobial surgical hydrogel for use in surgical and acute wounds, and DispersinB Gel for prosthetic joint infection. It also provides Scalp Detoxifier, Shampoo and Shampoo Bars. Its primary markets for its technologies are animal health and human health.


TSXV:KNE - Post by User

Bullboard Posts
Comment by CurlyMickon May 28, 2014 7:03pm
221 Views
Post# 22607652

RE:RE:RE:location, location, location....

RE:RE:RE:location, location, location....Hey George;

I may be in Montreal on June 4th and may go to the AGM, but if I do, it won't be to confront the BOD.

The BOD has not deceived any of us. This play (can't call a spec biotech on the V as any more than just a play) has proven to be a fun and wonderful ride.

I invest in many tech and biotech babies (start-ups) and this company of all has not fed me a BS line compared to most others, 9/10 which fail. Luckily I hit a few 10-100 bangers. You can write me if need be and I'll explain more and spill my guts about the disappointments and big bucks I've lost by the actions of other lying ventures.

The management at Kane has not pumped their story like most do. Kudos to Gord et al.

Kane (ok..granted only IMHO) is about to make an announcement of significnce for all us shareholders. I suspect it will be this week or early next....again...just MHO and speculation based on experience.

I love Winterpeg...especially when I borrow a parka in the winter or mosquito spray for the other two months, but Kane is moving out of the Golden Boy's view soon. It's time to move on.

Montreal makes complete sense for the AGM and Special Meeting if you look at who lives where and what's (possibly) going on.


GLTA long time believers.



Bullboard Posts